ODEVIXIBAT TREATMENT IN PATIENTS WITH FIC1 DEFICIENCY: SUSTAINED EFFICACY, PARTICULARLY IN PRURITUS, IN AN INTEGRATED ANALYSIS OF RESPONDERS (PEDFIC 1 AND PEDFIC 2)
(2025) 57TH Annual Meeting of ESPGHAN — Location: Helsinski, Finland (14.May.2025)
Files
No attached file found for this publication.
Details
- Authors
Thompson, R 
Sokal, Etienne - et. al.
- Abstract
- ODEVIXIBAT TREATMENT IN PATIENTS WITH FIC1 DEFICIENCY: SUSTAINED EFFICACY, PARTICULARLY IN PRURITUS, IN AN INTEGRATED ANALYSIS OF RESPONDERS (PEDFIC 1 AND PEDFIC 2)
- Affiliations
Citations
Verkade, H., Thompson, R., Artan, R., Calvo, P. L., Czubkowski, P., Dalgic, B., d’Antonio, L., Durmaz, O., Grammatikopoulos, T., Gupte, G., Hardikar, W., Kamath, B., Lacaille F, Lainka, E., Loomes, K., Mack, C. L., McKiernan, P., Ozen, H., Rajwal, S., et al. (2025). ODEVIXIBAT TREATMENT IN PATIENTS WITH FIC1 DEFICIENCY: SUSTAINED EFFICACY, PARTICULARLY IN PRURITUS, IN AN INTEGRATED ANALYSIS OF RESPONDERS (PEDFIC 1 AND PEDFIC 2). 57TH Annual Meeting of ESPGHAN, Helsinski, Finland. https://hdl.handle.net/2078.5/244182